Legacy Pharmaceutical Packaging, a contract packager serving the global pharmaceutical industry with bottling, blistering, pouching, unit-of-use, serialization, compliance and secondary packaging services, has purchased a 215,000-square-foot open-space facility to introduce comprehensive, wide-scale 3PL and distribution services. Located near the company’s headquarters in the St. Louis, MO area, the expansive building will extend Legacy’s servicing capabilities for OTC and Rx pharma customers well past its historic CPO roots, and bring the company’s total footprint to more than 500,000 square feet.
The new space allows Legacy to significantly grow its existing 3PL operations, with plans to divide the open-design building into dedicated departments, including those comprising new SKU handling and artwork, a retail management team for real-time inventory monitoring and reordering, an automated oversight initiative to best ensure quality and price competitiveness via enhanced efficiencies, and a warehousing and shipping wing to finalize and even deliver finished products.
The spacious building allows Legacy to continue to build on its full turnkey services, such as warehousing of bulk product to ultimately shorten product cycle times and afford customers an additional layer of safety stock to greatly reduce out of stock situations. This includes easier access points for OTC segments, which will further improve upon Legacy’s dedication to expeditious project turnaround and final delivery. For Rx products, expanded 3PL offerings will include an inventory portal, charge-back system, a serialization suite and a returns processing department. The result is an optimized process for all stakeholders: manufacturers, packaging suppliers and retailers.
The facility also provides room for strategic space utilization. For example, Legacy plans to transition its existing labeling cage, currently located at its nearby primary manufacturing plant, to its new annex, a move that will pave the way for streamlined, just-in-time labels delivery. The building also provides additional room for component overflow, as well as a place for newer initiatives, such as Legacy’s recent purchase of three high speed blistering and cartoning lines with serialization and aggregation capabilities from McKesson RxPak’s production facility in Memphis.
“The new facility allows us to dramatically ramp up third-party logistics and distribution services that we’ve already been performing for quite some time,” said Dave Spence, CEO of Legacy Pharmaceutical Packaging. “As the needs of our customers evolve, this provides an opportunity to offer a more comprehensive service offering well beyond our traditional role as a contract packaging organization. Increasingly, Legacy is becoming a turnkey, start-to-finish partner for preparing, finalizing and bringing finished products directly to market.”
About Legacy Pharmaceutical Packaging, LCC
Legacy Pharmaceutical Packaging is a privately held contract pharmaceutical packaging company located in St. Louis, Missouri. Legacy is a full service pharma solution & medical device packaging provider servicing the branded, generic, government, wholesale and major retail markets. Legacy is registered with the FDA, VAWD accredited and licensed by the DEA to handle Schedule II-V drug products.
The ABC’s of Brand Protection
PLEASE NOTE: many 2020 events have been postponed / cancelled due to the worldwide COVID-19 Coronavirus pandemic. We recommend that you check directly with organisers to obtain the latest information on events of interest.
Asia Security Conference & Exhibition
July 22-23, 2020 - Kuala Lumpur, Malaysia
International Food Fraud Conference
September 22-23, 2020 - Amsterdam, The Netherlands
Asian IP Forum (AIPF)
September 24-25, 2020 - Singapore
Global Brand Protection Summit 2020
September 24, 2020 - London, UK
European IP Forum
November 12-13, 2020 - Munich, Germany